NASA’s Antibiotic Effectiveness in Space (AES-1) investigation is launching in January and it will be offering scientists more insight into how bacteria behave in microgravity.
Bacteria are considered the most successful life forms, and they are hard to run from, even in space. In a microgravity environment, studies have shown that bacteria are able to survive antibiotic treatments that are meant to thwart the infectious microbes. Astronauts aboard the International Space Station have been stricken with infections during flights before, so understanding why bacteria are able to survive antibiotics in space is important for future missions to places like Mars.
NASA’s AES-1 experiment will be flying with Orbital’s Cygnus spacecraft in January to the space station to look into the reasons for antibiotic resistance in space. The experiment will help answer many questions scientists have about the phenomena.